Japanese
close

FI (list display)

  • A61P5/00
    		•  Drugs for disorders of the endocrine system [7] HB CC 4C201
  • A61P5/02
    		•  .of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin [7] HB CC 4C201
  • A61P5/04
    		•  ..for decreasing, blocking or antagonising the activity of the hypothalamic hormones [7] HB CC 4C201
  • A61P5/06
    		•  .of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH [7] HB CC 4C201
  • A61P5/08
    		•  ..for decreasing, blocking or antagonising the activity of the anterior pituitary hormones [7] HB CC 4C201
  • A61P5/10
    		•  .of the posterior pituitary hormones, e.g. oxytocin, ADH [7] HB CC 4C201
  • A61P5/12
    		•  ..for decreasing, blocking or antagonising the activity of the posterior pituitary hormones [7] HB CC 4C201
  • A61P5/14
    		•  .of the thyroid hormones, e.g. T3, T4 [7] HB CC 4C201
  • A61P5/16
    		•  ..for decreasing, blocking or antagonising the activity of the thyroid hormones [7] HB CC 4C201
  • A61P5/18
    		•  .of the parathyroid hormones [7] HB CC 4C201
  • A61P5/20
    		•  ..for decreasing, blocking or antagonising the activity of PTH [7] HB CC 4C201
  • A61P5/22
    		•  ..for decreasing, blocking or antagonising the activity of calcitonin [7] HB CC 4C201
  • A61P5/24
    		•  .of the sex hormones [7] HB CC 4C201
  • A61P5/26
    		•  ..Androgens [7] HB CC 4C201
  • A61P5/28
    		•  ..Antiandrogens [7] HB CC 4C201
  • A61P5/30
    		•  ..Oestrogens [7] HB CC 4C201
  • A61P5/32
    		•  ..Antioestrogens [7] HB CC 4C201
  • A61P5/34
    		•  ..Gestagens [7] HB CC 4C201
  • A61P5/36
    		•  ..Antigestagens [7] HB CC 4C201
  • A61P5/38
    		•  .of the suprarenal hormones [7] HB CC 4C201
  • A61P5/40
    		•  ..Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids [7] HB CC 4C201
  • A61P5/42
    		•  ..for decreasing, blocking or antagonising the activity of mineralocorticosteroids [7] HB CC 4C201
  • A61P5/44
    		•  ..Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids [7] HB CC 4C201
  • A61P5/46
    		•  ..for decreasing, blocking or antagonising the activity of glucocorticosteroids [7] HB CC 4C201
  • A61P5/48
    		•  .of the pancreatic hormones [7] HB CC 4C201
  • A61P5/50
    		•  ..for increasing or potentiating the activity of insulin [7] HB CC 4C201
    TOP